Roles of mitochondrial benzodiazepine receptor in the heart

Canadian Journal of Cardiology

Volumn 27, Issue 2, 2011, Pages 262.e3-262.e13

  Surinkaew, Sirirat ^a   Chattipakorn, Siriporn ^a   Chattipakorn, Nipon ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLOROPHENYL) N METHYL N (1 METHYL PROPYL) 3 ISOQUINOLINE CARBOXAMIDE; 4' CHLORODIAZEPAM; ADENOSINE TRIPHOSPHATE; BENZODIAZEPINE RECEPTOR; CARDIAC AGENT; CYCLOSPORIN A; HEART RECEPTOR; MITOCHONDRIAL BENZODIAZEPINE RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; REACTIVE SULFUR SPECIES; SSR 180575; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR;

ACUTE STRESS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; RECEPTOR AFFINITY; REPERFUSION INJURY; REVIEW; TACHYCARDIA; ANIMAL; HEART CONTRACTION; HEART DISEASE; HEART RATE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HEART DISEASES; HEART RATE; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; RECEPTORS, GABA-A;

EID: 79957995104     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.023     Document Type: Review

References (83)

1. Awad M, Gavish M. Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J Neurochem 1987;49:1407-14.
2. Le Fur G, Guilloux F, Rufat P, et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci 1983;32: 1849-56.
3. Le Fur G, Perrier ML, Vaucher N, et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci 1983; 32:1839-47.
4. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A 1977;74:3805-9.
5. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 1986;261:576-83.
6. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A 1992;89:3170-4.
7. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 1999;59:831-42.
8. Woods MJ, Williams DC. Multiple forms and locations for the peripheral-type benzodiazepine receptor. Biochem Pharmacol 1996;52: 1805-14.
9. Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002;40:475-86.
10. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006;27:402-9.
11. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 2008;118:1-17.
12. Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther 2006;110:503-24.
13. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF, Shively JE. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropindependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad SciU S A 1989;86:4897-901.
14. Alho H, Varga V, Krueger KE. Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. Cell Growth Differ 1994;5:1005-14.
15. Taketani S, Kohno H, Furukawa T, Tokunaga R. Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. J Biochem 1995;117:875-80.
16. James ML, Selleri S, Kassiou M. Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem 2006;13:1991-2001.
17. Campiani G, Fiorini I, De Filippis MP, et al. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. J Med Chem 1996;39:2922-38.
18. Kragie L, Smiehorowski R. Altered peripheral benzodiazepine receptor binding in cardiac and liver tissues from thyroidectomized rats. Life Sci 1994;55:1911-8.
19. Saano V, Rago L, Tupala E, Airaksinen MM. Changes in GABAbenzodiazepine receptor complex and in peripheral benzodiazepine receptors in male mice after copulation. Pharmacol Biochem Behav 1995;51:529-33.
20. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. Characterization of stress-induced alterations in [3H] Ro5-4864 binding to peripheral benzodiazepine receptors in rat heart and kidney. Pharmacol Biochem Behav 1988;30:1015-20.
21. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. Inescapable shock reduces [3H]Ro 5-4864 binding to "peripheral-type" benzodiazepine receptors in the rat. Pharmacol Biochem Behav 1986;24:1673-7.
22. Basile AS, Weissman BA, Skolnick P. Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex. Brain Res Bull 1987;19:1-7.
23. Salvetti F, Chelli B, Gesi M, et al. Effect of noise exposure on rat cardiac peripheral benzodiazepine receptors. Life Sci 2000;66:1165-75.
24. Obame FN, Zini R, Souktani R, Berdeaux A, Morin D. Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. J Pharmacol Exp Ther 2007;323:336-45.
25. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. "Peripheral" benzodiazepine binding sites in the Maudsley reactive rat: selective decrease confined to peripheral tissues. Brain Res Bull 1987;18:143-5.
26. Gavish M, Katz Y, Bar-Ami S, Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J Neurochem 1992;58:1589-601.
27. Mestre M, Carriot T, Belin C, et al. Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart. Life Sci 1985;36:391-400.
28. Mestre M, Carriot T, Belin C, et al. Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sci 1984;35:953-62.
29. 2+ channel. Eur J Pharmacol 1985;118:293-301.
30. Edoute Y, Giris J, Ben-Haim SA, et al. Ro 5-4864 and PK 11195, but not diazepam, depress cardiac function in an isolated working rat heart model. Pharmacology 1993;46:224-30.
31. Saegusa K, Furukawa Y, Ogiwara Y, Takeda M, Chiba S. Pharmacologic basis of responses to midazolam in the isolated, cross-perfused, canine right atrium. Anesth Analg 1987;66:711-8.
32. Brown DA, Aon MA, Akar FG, et al. Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart. Cardiovasc Res 2008;79:141-9.
33. Leeuwin RS, Zeegers A, van Hamme J, van Wilgenburg H. Modification of cardiac actions of RO 05-4864 by PK 11195 and flumazenil in the perfused rat heart. Life Sci 1997;61:1631-42.
34. Grupp IL, French JF, Matlib MA. Benzodiazepine Ro 5-4864 increases coronary flow. Eur J Pharmacol 1987;143:143-7.
35. Weissman BA, Bolger GT, Chiang PK. Interactions between nitrogen oxide-containing compounds and peripheral benzodiazepine receptors. FEBS Lett 1990;260:169-72.
36. Charbonneau P, Syrota A, Crouzel C, et al. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 1986;73:476-83.
37. Le Fur G, Vaucher N, Perrier ML, et al. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 1983;33:449-57.
38. Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci U S A 1989;86:9813-6.
39. Akar FG, Aon MA, Tomaselli GF, O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 2005;115:3527-35.
40. Li J, Xiao J, Liu Y, et al. Mitochondrial benzodiazepine receptors mediate cardioprotection of estrogen against ischemic ventricular fibrillation. Pharmacol Res 2009;60:61-7.
41. Mangoni ME, Marger L, Nargeot J. If current inhibition: cellular basis and physiology. Adv Cardiol 2006;43:17-30.
42. Lundberg KC, Szweda LI. Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch Biochem Biophys 2004;432:50-7.
43. Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 2001; 276:12030-4.
44. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003;93:292-301.
45. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 1988;82: 476-85.
46. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 1987;84:1404-7.
47. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000;192:1001-14.
48. Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005;280:12944-55.
49. Leducq N, Bono F, Sulpice T, et al. Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion. J Pharmacol Exp Ther 2003;306: 828-37.
50. Mestre M, Bouetard G, Uzan A, et al. PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog. Eur J Pharmacol 1985; 112:257-60.
51. Vin V, Leducq N, Bono F, Herbert JM. Binding characteristics of SSR180575, a potent and selective peripheral benzodiazepine ligand. Biochem Biophys Res Commun 2003;310:785-90.
52. Ferzaz B, Brault E, Bourliaud G, et al. SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]i ndole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. J Pharmacol Exp Ther 2002;301:1067-78.
53. Chelli B, Falleni A, Salvetti F, et al. Peripheral-type benzodiazepine receptor ligands: mitochondrial permeability transition induction in rat cardiac tissue. Biochem Pharmacol 2001;61:695-705.
54. Yang JC, Cortopassi GA. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med 1998;24:624-31.
55. Steenbergen C, Murphy E, Watts JA, London RE. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 1990;66:135-46.
56. Moreno-Sanchez R, Hogue BA, Bravo C, et al. Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086. Biochem Pharmacol 1991;41:1479-84.
57. Li J, Wang J, Zeng Y. Peripheral benzodiazepine receptor ligand, PK11195 induces mitochondria cytochrome c release and dissipation of mitochondria potential via induction of mitochondria permeability transition. Eur J Pharmacol 2007;560:117-22.
58. 2+ from heart and kidney mitochondria by peripheral-type benzodiazepine receptor ligands. Int J Biochem 1991;23:207-13.
59. Balasubramaniam R, Chawla S, Mackenzie L, et al. Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts. Pflugers Arch 2004;449:150-8.
60. Baxter GF, Yellon DM. Attenuation of reperfusion-induced ventricular fibrillation in the rat isolated hypertrophied heart by preischemic diltiazem treatment. Cardiovasc Drugs Ther 1993;7:225-31.
61. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307 (Pt 1):93-8.
62. Huser J, Blatter LA. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J 1999;343 Pt 2:311-7.
63. O'Rourke B. Pathophysiological and protective roles of mitochondrial ion channels. J Physiol 2000;529 Pt 1:23-36.
64. Kinnally KW, Zorov DB, Antonenko YN, et al. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc Natl Acad Sci U S A 1993;90:1374-8.
65. Berkich DA, Salama G, LaNoue KF. Mitochondrial membrane potentials in ischemic hearts. Arch Biochem Biophys 2003;420:279-86.
66. Aon MA, Cortassa S, Marban E, O'Rourke B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 2003;278: 44735-44.
67. Ambrosio G, Zweier JL, Duilio C, et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 1993;268: 18532-41.
68. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999;26:463-71.
69. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998;273:18092-8.
70. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-16.
71. Hess ML, Manson NH. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 1984;16:969-85.
72. Sasaki N, Sato T, Ohler A, O'Rourke B, Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 2000;101:439-45.
73. Sato T, O'Rourke B, Marban E. Modulation of mitochondrial ATPdependent K+ channels by protein kinase C. Circ Res 1998;83:110-4.
74. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995;270:296-9.
75. Aon MA, Cortassa S, Maack C, O'Rourke B. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J Biol Chem 2007;282:21889-900.
76. Von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999;99:2934-41.
77. O'Rourke B, Ramza BM, Marban E. Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science 1994;265:962-6.
78. Romashko DN, Marban E, O'Rourke B. Subcellular metabolic transients and mitochondrial redox waves in heart cells. Proc Natl Acad Sci U S A 1998;95:1618-23.
79. on MA, Cortassa S, O'Rourke B. Percolation and criticality in a mitochondrial network. Proc Natl Acad Sci U S A 2004;101:4447-52.
80. Romeo E, Auta J, Kozikowski AP, et al. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J Pharmacol Exp Ther 1992;262:971-8.
81. Dumont F, De Vos F, Versijpt J, et al. In vivo evaluation in mice and metabolism in blood of human volunteers of [123I]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation. Eur J Nucl Med 1999;26:194-200.
82. Versijpt J, Dumont F, Thierens H, et al. Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor. Eur J Nucl Med 2000;27:1326-33.
83. Drobinski G, Lechat P, Eugene L, Grosgogeat Y. [Absence of an antiischemic effect of the peripheral benzodiazepine receptor antagonist PK 11195. Study by atrial stimulation in man]. Therapie 1989;44:263-7.